Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | IDH1 | O75874 | 1/20 | 0.36 |
| ▸ | IDH2 | P48735 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | SOS1 | Q07889 | 1/20 | 0.30 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.30 |
| ▸ | AHR | P35869 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | NPR3 | P17342 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL692464 | 0.97 | GAA (0.33) | GAATDP1IDH1IDH2LMNA | |
| SCHEMBL7481323 | 0.93 | IDH1 (0.34) | GAAIDH1IDH2LMNAKDM4E | |
| SCHEMBL10811643 | 0.91 | KMT2A (0.35) | GAATDP1IDH1IDH2LMNA | |
| SCHEMBL3145067 | 0.90 | KMT2A (0.36) | GAATDP1IDH1IDH2LMNA | |
| SCHEMBL10934656 | 0.90 | KMT2A (0.36) | GAATDP1IDH1IDH2LMNA | |
| SCHEMBL10912239 | 0.88 | KMT2A (0.32) | GAATDP1KMT2A | |
| SCHEMBL11451173 | 0.88 | KMT2A (0.33) | GAALMNAKMT2A | |
| SCHEMBL10910238 | 0.87 | KMT2A (0.34) | GAATDP1KMT2A | |
| SCHEMBL11031866 | 0.87 | KMT2A (0.34) | GAATDP1KMT2A | |
| SCHEMBL8838268 | 0.86 | IDH1 (0.31) | GAAIDH1IDH2LMNAKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-4225974-A | — | — | None | — | — | JP | disclosed |
| US-9963575-B2 | Sterically hindered amine light stabilizers with a mixed functionalization | BASF SE (DE) | 2018-05-08 | — | — | US | disclosed |
| US-20170107352-A1 | STERICALLY HINDERED AMINE LIGHT STABILIZERS WITH A MIXED FUNCTIONALIZATION | BASF SE (DE) | 2017-04-20 | — | — | US | disclosed |
| US-9550941-B2 | Sterically hindered amine light stabilizers with a mixed functionalization | BASF SE (DE) | 2017-01-24 | — | — | US | disclosed |
| EP-2630137-B1 | STERICALLY HINDERED AMINE LIGHT STABILIZERS WITH MIXED FUNCTIONALIZATION | BASF SE (DE) | 2015-04-01 | — | — | EP | disclosed |
| US-8830811-B2 | Resin composition and optical component | MITSUI CHEMICALS, INC. (JP) | 2014-09-09 | — | — | US | disclosed |
| EP-2630137-A1 | STERICALLY HINDERED AMINE LIGHT STABILIZERS WITH MIXED FUNCTIONALIZATION | BASF SE (DE) | 2013-08-28 | — | — | EP | disclosed |
| US-20130207043-A1 | STERICALLY HINDERED AMINE LIGHT STABILIZERS WITH A MIXED FUNCTIONALIZATION | BASF SE (DE) | 2013-08-15 | — | — | US | disclosed |
| EP-1878769-B1 | RESIN COMPOSITION AND OPTICAL COMPONENT | MITSUI CHEMICALS INC (JP) | 2013-04-17 | — | — | EP | disclosed |
| US-8354529-B2 | Polyamine derivative and polyol derivative | BASF SE (DE) | 2013-01-15 | — | — | US | disclosed |
| EP-0314472-A2 | Novel piperidyl-triazine derivatives and their use as polymer stabilizers | Sankyo Company Limited (JP) | 1989-05-03 | — | — | EP | disclosed |
| US-4760141-A | Hydrocarbyl(polyphenol)-poly(2,2,6,6-tetramethyl piperidyl-1,3,5-triazines) as stabilizers for synthetic polymer compositions | ADEKA ARGUS CHEMICAL CO., LTD. (JP) | 1988-07-26 | — | — | US | disclosed |
| US-4759871-A | Stabilizing the polymer from deterioration upon exposure to light and heat | ADEKA ARGUS CHEMICAL CO., LTD. (JP) | 1988-07-26 | — | — | US | disclosed |
| US-4740544-A | Hydrocarbyl(polyphenol)-poly(2,2,6,6-tetramethyl piperidyl-1,3,5-triazines) as stabilizers for synthetic polymer compositions | ADEKA ARGUS CHEMICAL CO., LTD. (JP) | 1988-04-26 | — | — | US | disclosed |
| EP-0075849-B1 | TRIAZINYLLACTAMES, PROCESS FOR THEIR PREPARATION, THEIR USE AS STABILISATORS FOR SYNTHETIC ORGANIC POLYMERS AND POLYMERS STABILISED BY THEM | HOECHST AKTIENGESELLSCHAFT (DE) | 1987-07-22 | — | — | EP | disclosed |
| EP-0209126-A2 | Hydrocarbyl(polyphenol)-poly(2,2,6,6-tetramethyl piperidyl-1,3,5-triazines) as stabilizers for synthetic polymer compositions | ADEKA ARGUS CHEMICAL CO., Ltd. (JP) | 1987-01-21 | — | — | EP | disclosed |
| US-4504661-A | PHOTOSTABILIZERS | HOECHST AKTIENGESELLSCHAFT (DE) | 1985-03-12 | — | — | US | disclosed |
| EP-0075849-A2 | Triazinyllactames, process for their preparation, their use as stabilisators for synthetic organic polymers and polymers stabilised by them | HOECHST AKTIENGESELLSCHAFT (DE) | 1983-04-06 | — | — | EP | disclosed |
| EP-0042554-A1 | Polytriazinyl amines, process for their preparation, their use as stabilizing agents for synthetic polymers and polymers stabilized with these compounds | HOECHST AKTIENGESELLSCHAFT (DE) | 1981-12-30 | — | — | EP | disclosed |
| US-4234707-A | Polymeric light stabilizers for plastics | CIBA-GEIGY CORPORATION (US) | 1980-11-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130207043-A1 | STERICALLY HINDERED AMINE LIGHT STABILIZERS WITH A MIXED FUNCTIONALIZATION | C1S, H1-0, H1-2 | GAA 4492/4885TDP1 4246/4885IDH1 3394/4885 |
| US-20170107352-A1 | STERICALLY HINDERED AMINE LIGHT STABILIZERS WITH A MIXED FUNCTIONALIZATION | C1S, H1-0, H1-2 | GAA 4426/4885TDP1 4146/4885IDH1 3469/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.